Expression of MicroRNAs in Patients With Pancreatic Cancer and Its Prognostic Significance
Expression of MicroRNAs in Patients With Pancreatic Cancer and Its Prognostic Significance
复制标题
DOI:
10.1097/mpa.0b013e3182592ba7
复制
发表时间:
2013-01-01
期刊:
影响因子:
2.9
通讯作者:
Voros, Dionysios
中科院分区:
文献类型:
--
作者:
Papaconstantinou, Ioannis G.;Manta, Asimina;Voros, Dionysios
Objectives: Investigation of expression profile of well-established microRNAs in pancreatic adenocarcinoma, and its correlation with clinicopathological factors.Methods: Eighty-eight samples of ductal pancreatic adenocarcinoma and 98 control samples were analyzed by real-time polymerase chain reaction for miR-21, miR-31, miR-122, miR-145, miR-146a, miR-155, miR-210, and miR-222 expressions. The results were normalized and then statistically analyzed using nonparametric statistical tests.Results: According to our results, miR-21, miR-155, miR-210, miR-221, and miR-222, were overexpressed in diseased tissues than in the control samples, whereas miR-31, miR-122, miR-145, and miR-146a were underexpressed. Additionally, the expressions of miR-21 and miR-155 were associated with tumor stage and poor prognosis.Conclusions: The tumorigenic role of miR-21 and miR-155 was confirmed, whereas down-regulation of miR-31, miR-145, and miR-146a, in dispute with current literature, renders necessary the revision of use of microRNAs as biological markers.